Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from KimberlyClark

Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks

Institutional insiders are placing big bets on DASH, KVUE, and KYMR. See how much is being spent on these three stocks and which investors are buying.

MarketBeat

Kimberly-Clark exec says old bosses would compare her to their daughters when she got promoted

Only 18% of chief supply chain officers in the F500 are women, including Kimberly-Clark’s Tamera Fenske. But she doesn’t just pay it forward to women in her footsteps, because men are ‘one of the strongest advocates.’

Fortune

Is Kimberly-Clark Stock Underperforming the Nasdaq?

While Kimberly-Clark has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Kimberly-Clark Stock: Is Wall Street Bullish or Bearish?

As Kimberly-Clark has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Sticker Shock: Why Kimberly-Clark's Sell-Off Is an Overreaction

Kimberly-Clark's acquisition of Kenvue creates a global leader in health and wellness, positioning its iconic brands for accelerated long-term growth.

MarketBeat

Kimberly-Clark Snaps Up Tylenol Maker Kenvue in £30 Billion Takeover Amid Autism Controversy

Kimberly-Clark to acquire Kenvue, owner of Tylenol, in a £40 billion deal amid controversy over the painkiller's safety concerns and declining sales.

International Business Times UK

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred renewed interest in the sector, setting up a potential reshuffling of weightings across several big-name ETFs.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Stocks Close Higher on M&A and AI Optimism

The S&P 500 Index ($SPX ) (SPY ) on Monday rose +0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) fell -0.52%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) rose +0.37%. December E-mini S&P futures (ESZ25 ) rose +0.09%, and December E-mini Nasdaq futures (NQZ25 ) rose...

Barchart

Kimberly-Clark Confirms Kenvue Acquisition Deal: Why It Is Buying the Tylenol Maker

Kimberly-Clark's acquisition of Kenvue marks a major strategic shift as the company expands beyond its traditional personal care and diving deeper into the consumer health market.

International Business Times UK

Amazon Surge Sends S&P 500, Nasdaq Higher to Start November: Stock Market Today

Amazon inked a $38 billion cloud deal with OpenAI, which sent the stock to the top of the Dow Jones on Monday.

Kiplinger

Kenvue Stock Pops on News Kimberly-Clark Will Buy It for $48.7B. Is It Too Late to Buy KVUE Here?

Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares heading into 2026.

Barchart

Kenvue Acquired by Kimberly-Clark in $48.7 Billion Deal to Form Consumer Staples Giant

Kimberly-Clark will acquire Kenvue in a $48.7 billion cash-and-stock deal, creating a new consumer health and personal care giant combining brands like Huggies, Kleenex, Johnson's Baby, and Band-Aid.

International Business Times UK

Stocks See Support From M&A and AI Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.08% the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. December E-mini S&P futures (ESZ25 ) are up +0.16%, and December E-mini Nasdaq futures...

Barchart

Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Kleenex maker’s deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutiny

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Tylenol maker sells to Kimberly Clark for $48B weeks after Trump and RFK Jr targeted drug

The deal announced Monday is among the largest corporate takeovers of the year

Benzinga

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Shares of Kimberly-Clark Corporation (NASDAQ:KMB) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE:KVUE) on Monday. Meanwhile Kenvue stock surged 20.04%.

MarketBeat

3 Safe and Steady Stocks for Any Market

Coca-Cola, Kimberly-Clark, and Healthpeak Properties offer stable dividends and steady growth, making them safe stocks for any market environment

Benzinga

Kimberly-Clark Proves Resilient With Firm Sales In Shifting Market

Kimberly-Clark Corporation (NASDAQ:KMB) shares were trading higher in the premarket session on Thursday after the company reported third-quarter fiscal 2025 results.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

The Saturday Spread: Use Distributional Bifurcation to Roadmap Your Options Trades

You wouldn’t dare fly in an airplane that wasn’t equipped with a working altimeter. It’s the same principle when it comes to data science and options trading.

Barchart

Earnings Preview: What to Expect From Kimberly-Clark’s Report

Consumer staples giant Kimberly-Clark will report its Q3 results soon. What should you expect from it?

Kiplinger

Investing Freebies: Perks You Get for Owning These Stocks

While the biggest investing returns come over the long term, these companies offer instant gratification for investors with several freebies and perks.

Barchart

Is Kimberly-Clark Stock Underperforming the S&P 500?

Kimberly-Clark has lagged behind the broader S&P 500 Index over the past year, yet analysts on Wall Street remain moderately optimistic about its future prospects.

Benzinga

Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs

Kimberly-Clark Corporation (NASDAQ:KMB) will pay $40.4 million to settle a criminal charge related to selling adulterated MicroCool surgical gowns.

Benzinga

Kimberly-Clark Analysts Boost Their Forecasts After Upbeat Q2 Earnings

Kimberly-Clark Corporation (NASDAQ:KMB) posted better-than-expected earnings for the second quarter on Friday.

Barchart

Kimberly-Clark's Quarterly Earnings Preview: What You Need to Know

Kimberly-Clark is set to report its second-quarter results later this month, and analysts are forecasting a double-digit drop in earnings.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.